Bronchial asthma: Update on the revised guidelines for diagnosis and management

Primary Care - Clinics in Office Practice

Volumn 25, Issue 4, 1998, Pages 849-867

  Andrew Grant, J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; NEDOCROMIL;

ALLERGIC REACTION; ASTHMA; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; METERED DOSE INHALER; MONITORING; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT;

EID: 0031797617     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0095-4543(05)70092-0     Document Type: Review

References (37)

1. M.J. Abramson R.M. Puy J.M. Weiner Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials [see comments] Am J Respir Crit Care Med 151 1995 969 974
2. R. Alam J.A. Grant The chemokines and the histamine-releasing factors: Modulation of function of basophils, mast cells and eosinophils Chem Immunol 61 1995 148 160
3. R. Alam J. York M. Boyars Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients Am J Respir Crit Care Med 153 1996 1398 1404
4. E.W. Alton A.A. Norris Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma J Allergy Clin Immunol 98 1996 102 106
5. P.J. Barnes Cytokines as mediators of chronic asthma Am J Respir Crit Care Med 150 1994 42 49
6. P.J. Barnes S. Pedersen Efficacy and safety of inhaled corticosteroids in asthma American Review of Respiratory Disease. 148 1993 1 26
7. A.M. Bentley G. Menz C. Storz Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness American Review of Respiratory Disease. 146 1992 500 506
8. J. Bousquet P. Chanez J.Y. Lacoste Eosinophilic inflammation in asthma N Engl J Med 323 1990 1033 1039
9. W.W. Busse The effect of treatment with corticosteroids on asthma airway structure and function Chest 107 1995 136 138
10. L. Butani E.J. O'Connell Functional respiratory disorders Ann Allergy Asthma Immunol 79 1997 91 101
11. A. Chetta A. Foresi M. Del Donno Airways remodeling is a distinctive feature of asthma and is related to severity of disease Chest 111 1997 852 857
12. R.O. Crapo Pulmonary-function testing N Engl J Med 331 1994 25 30
13. R.G. Cumming P. Mitchell S.R. Leeder Use of inhaled corticosteroids and the risk of cataracts N Engl J Med 337 1997 8 14
14. D.J. Evans D.A. Taylor O. Zetterstrom A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma N Engl J Med 337 1997 1412 1418
15. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma 1997 National Institutes of Health publication Washington, DC 97–4051
16. S.J. Galli Complexity and redundancy in the pathogenesis of asthma: Reassessing the roles of mast cells and T cells J Exp Med 186 1997 343 347
17. E. Garbe J. LeLorier J.F. Boivin S. Suissa Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle JAMA 277 1997 722 727
18. J.A. Grant M. Humbert L. Taborda-Barata High-affinity IgE receptor Fc, RI expression in allergic reactions Int Arch Allergy Immunol 113 1997 376 378
19. J.A. Grant C.F. Nicodemus S.R. Findlay Cetirizine in patients with seasonal rhinitis and concomitant asthma: Prospective, randomized, placebo-controlled trial J Allergy Clin Immunol 95 1995 923 932
20. T. Haahtela M. Jarvinen T. Kava Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma N Engl J Med 331 1994 700 705
21. R.J. Horwitz W.W. Busse Inflammation and asthma Clin Chest Med 16 1995 583 602
22. M. Humbert J.A. Grant L. Taborda-Barata High-affinity IgE receptor (Fc,RI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma Am J Respir Crit Care Med 153 1996 1931 1937
23. J.M. Ignacio-Garcia P. Gonzalez-Santos Asthma self-management education program by home monitoring of peak expiratory flow Am J Respir Crit Care Med 151 1995 353 359
24. E.F. Juniper G.H. Guyatt P.J. Ferrie L.E. Griffith Measuring quality of life in asthma American Review of Respiratory Disease. 147 1993 832 838
25. A.B. Kay TH2-type cytokines in asthma Ann N Y Acad Sci 796 1996 1 8
26. T. Koshino Y. Arai Y. Miyamoto Airway basophil and mast cell density in patients with bronchial asthma: Relationship to bronchial hyperresponsiveness J Asthma 33 1996 89 95
27. M.C. Liu L.M. Dube J. Lancaster Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial J Allergy Clin Immunol 98 1996 859 871
28. A. Malick J.A. Grant Antihistamines in the treatment of asthma Allergy 52 1997 55 66
29. E.R. McFadden Jr N. el Sanadi L. Strauss The influence of parasympatholytics on the resolution of acute attacks of asthma Am J Med 102 1997 7 13
30. N.M. Munoz I. Douglas D. Mayer Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism Am J Respir Crit Care Med 155 1997 1398 1403
31. T.A. Platts-Mills M.C. Carter Asthma and indoor exposure to allergens N Engl J Med 336 1997 1382 1384
32. M.R. Sears D.R. Taylor C.G. Print Regular inhaled beta-agonist treatment in bronchial asthma Lancet. 336 1990 1391 1396
33. S.L. Spector R.A. Nicklas Practice parameters for the diagnosis and treatment of asthma J Allergy Clin Immunol 96 1995 707 870
34. S. Suissa R. Dennis P. Ernst Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial Ann Intern Med 126 1997 177 183
35. S. Suissa P. Ernst J.F. Boivin A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists Am J Respir Crit Care Med 149 1994 604 610
36. K.M. Venables M. Chan-Yeung Occupational asthma Lancet. 349 1997 1465 1469
37. A. Woolcock B. Lundback N. Ringdal L.A. Jacques Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids Am J Respir Crit Care Med 153 1996 1481 1488